Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: A multiplex analysis

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 4, 2015, Pages 575-581

  Jekarl, Dong Wook ^a,b   Kim, Ji Yeon ^a,b   Lee, Seungok ^a,b   Kim, Myungshin ^b,c   Kim, Yonggoo ^b,c   Han, Kyungja ^c   Woo, Seon Hee ^a   Lee, Woon Jeong ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

cytokine profiles; immature granulocyte; interferon ; procalcitonin; sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GRANULOCYTE; HUMAN; IMMUNOASSAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; CYTOLOGY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

CYTOKINES; FEMALE; GRANULOCYTES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84925762421     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0607     Document Type: Article

References (22)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
2. Marino R, Struck J, Maisel A, Magrini L, Bergmann A, Somma S. Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis. Crit Care 2014;18:1-7.
3. Giamarellos-Bourboulis EJ, Mega A, Grecka P. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002;28:1351-6.
4. Jekarl DW, Lee SY, Lee J, Park YJ, Kim YG, Park JH, et al. Procalci-tonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013;75:342-7.
5. Ventetudo C, Levy M. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008;29:591-603.
6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
7. Cimenti C, Erwa W, Herkner K, Kasper D, Muller W, Resch B. The predictive value of immature granulocyte count and immature myeloid information in the diagnosis of neonatal sepsis. Clin Chem Lab Med 2012;50:1429-32.
8. Park DH, Park K, Park J, Park HH, Chae H, Lim J, et al. Screening of sepsis using leukocyte cell population data from the Coulter automatic blood cell analyzer DxH800. Int J Lab Hem 2011;33:391-9.
9. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau G, et al. Diagnostic value of procalcitonin, interleukin-6 and inter-leukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
10. Chalupa P, Beran O, Herwald H, Kasprikova N, Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011;39:411-7.
11. Lvovschi V, Arnaud L, Parizot C, Freund Y, Juillien G, Ghillani-Dalbin P, et al. Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational study. PLoS One 2011;6:1-13.
12. Bozza F, Salluh J, Japiassu A, Soares M, Assis E, Gomes R, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11:1-8.
13. Mera S, Tatulescu D, Cismaru C, Bondor C, Slavcovici A, Zanc V, et al. Multiplex cytokine profiling in patients with sepsis. APMIS 2010;119:155-63.
14. Maenhout TM, Marcelis L. Immature granulocyte count in peripheral blood by the Sysmex haematology XN series compared to microscopic differentiation. J Clin Pathol 2014;67:648-50.
15. Kim MJ, Jang JW, Oh BS, Kwon JH, Chung KW, Jung HS, et al. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma. Cytokine 2013;64:516-22.
16. Crawley M. Multivariate analysis. In The R book. West Sussex: John Wiley & Sons, Ltd, 2007:731-47.
17. Angus D, Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51.
18. Tang B, Eslick G, Craig J, McLean A. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
19. Afshari A, Harbarth S. Procalcitonin as diagnostic biomarker of sepsis. Lancet Infect Dis 2013;13:382-4.
20. Moyer MW. New biomarkers sought for improving sepsis management and care. Nat Med 2013;18:999.
21. Magrini L, Gagliano G, Travaglino F, Vetrone F, Marino R, Cardelli P, et al. Comparison between white blood cell count, procalcitonin and C reactive protein as a diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med 2014;52:1465-72.
22. Boomer J, Shuherk-Shaffer J, Hotchkiss R, Green JM. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care 2012;16:1-14.